SG11202009359WA - Methods and assays for modulating gene transcription by modulating condensates - Google Patents
Methods and assays for modulating gene transcription by modulating condensatesInfo
- Publication number
- SG11202009359WA SG11202009359WA SG11202009359WA SG11202009359WA SG11202009359WA SG 11202009359W A SG11202009359W A SG 11202009359WA SG 11202009359W A SG11202009359W A SG 11202009359WA SG 11202009359W A SG11202009359W A SG 11202009359WA SG 11202009359W A SG11202009359W A SG 11202009359WA
- Authority
- SG
- Singapore
- Prior art keywords
- modulating
- condensates
- assays
- methods
- gene transcription
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862647613P | 2018-03-23 | 2018-03-23 | |
US201862648377P | 2018-03-26 | 2018-03-26 | |
US201862722825P | 2018-08-24 | 2018-08-24 | |
US201862752332P | 2018-10-29 | 2018-10-29 | |
US201962819662P | 2019-03-17 | 2019-03-17 | |
US201962820237P | 2019-03-18 | 2019-03-18 | |
PCT/US2019/023694 WO2019183552A2 (en) | 2018-03-23 | 2019-03-22 | Methods and assays for modulating gene transcription by modulating condensates |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202009359WA true SG11202009359WA (en) | 2020-10-29 |
Family
ID=67987575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202009359WA SG11202009359WA (en) | 2018-03-23 | 2019-03-22 | Methods and assays for modulating gene transcription by modulating condensates |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220120736A1 (en) |
EP (1) | EP3768329A4 (en) |
JP (2) | JP2021535737A (en) |
KR (1) | KR20210070233A (en) |
CN (1) | CN113164622A (en) |
AU (1) | AU2019239084A1 (en) |
CA (1) | CA3094974A1 (en) |
IL (1) | IL277533A (en) |
SG (1) | SG11202009359WA (en) |
TW (1) | TW202003051A (en) |
WO (1) | WO2019183552A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020061251A1 (en) * | 2018-09-20 | 2020-03-26 | The Trustees On Princeton University | High throughput method and system for mapping intracellular phase diagrams |
CA3127237A1 (en) | 2019-02-08 | 2020-08-13 | Dewpoint Therapeutics, Inc. | Methods of characterizing condensate-associated characteristics of compounds and uses thereof |
CN114173879A (en) * | 2019-05-15 | 2022-03-11 | 怀特黑德生物医学研究所 | Methods of characterizing and utilizing agent-aggregate interactions |
WO2021055644A1 (en) | 2019-09-18 | 2021-03-25 | Dewpoint Therapeutics, Inc. | Methods of screening for condensate-associated specificity and uses thereof |
WO2021150937A1 (en) * | 2020-01-23 | 2021-07-29 | The Rockefeller University | Phase separation sensors and uses thereof |
CN111269976A (en) * | 2020-02-03 | 2020-06-12 | 清华大学 | Application of MeCP2 mutation detection substance in detecting whether MeCP2 mutation is pathogenic mutation or not and screening drugs |
CN111487399B (en) * | 2020-03-26 | 2021-09-17 | 湖南师范大学 | Application of protein molecular marker in research on fish germ cell development |
CN111471713A (en) * | 2020-04-23 | 2020-07-31 | 北京大学 | Method for controlling intracellular mRNA positioning and translation process based on controllable phase separation liquid drops |
US20230236190A1 (en) * | 2020-06-18 | 2023-07-27 | Whitehead Institute For Biomedical Research | Viral condensates and methods of use thereof |
IL301029A (en) | 2020-09-01 | 2023-05-01 | Univ Brown | Targeting enhancer rnas for the treatment of primary brain tumors |
US20240309365A1 (en) * | 2020-11-25 | 2024-09-19 | Whitehead Institute For Biomedical Research | Modulating transcriptional condensates |
WO2022171163A1 (en) * | 2021-02-10 | 2022-08-18 | Etern Biopharma (Shanghai) Co., Ltd. | Methods of modulating androgen receptor condensates |
KR20230174216A (en) * | 2021-03-02 | 2023-12-27 | 듀포인트 테라퓨틱스, 인크. | Condensate phenotypic identification methods and uses thereof |
WO2022187202A1 (en) * | 2021-03-02 | 2022-09-09 | Dewpoint Therapeutics, Inc. | New condensate paradigms |
WO2022212872A1 (en) * | 2021-04-02 | 2022-10-06 | Case Western Reserve University | Methods and compositions for accelerating oligodendrocyte maturation |
CN113254499B (en) * | 2021-05-21 | 2023-09-29 | 国家卫星气象中心(国家空间天气监测预警中心) | Climate data set production method based on long-sequence historical data recalibration |
WO2023014989A1 (en) * | 2021-08-05 | 2023-02-09 | Whitehead Institute For Biomedical Research | Methods and agents for decreasing insulin resistance |
WO2024001989A1 (en) * | 2022-06-27 | 2024-01-04 | Etern Biopharma (Shanghai) Co., Ltd. | Compositions and methods for modulating molecules |
WO2024174065A1 (en) * | 2023-02-20 | 2024-08-29 | 清华大学 | Dual transcription factor, and transcription regulation system and transcription regulation method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2431047A1 (en) * | 2000-11-13 | 2002-05-16 | Christopher C. Adams | Methods for determining the biological effects of compounds on gene expression |
WO2006063356A1 (en) * | 2004-12-10 | 2006-06-15 | Isis Phamaceuticals, Inc. | Regulation of epigenetic control of gene expression |
US20170233762A1 (en) * | 2014-09-29 | 2017-08-17 | The Regents Of The University Of California | Scaffold rnas |
EP3233846A4 (en) * | 2014-12-17 | 2018-07-18 | Zenith Epigenetics Ltd. | Inhibitors of bromodomains |
US20190194150A1 (en) * | 2016-07-01 | 2019-06-27 | Arrakis Therapeutics, Inc. | Compounds and methods for modulating rna function |
-
2019
- 2019-03-22 KR KR1020207029166A patent/KR20210070233A/en not_active Application Discontinuation
- 2019-03-22 US US17/040,967 patent/US20220120736A1/en active Pending
- 2019-03-22 CA CA3094974A patent/CA3094974A1/en active Pending
- 2019-03-22 TW TW108110178A patent/TW202003051A/en unknown
- 2019-03-22 SG SG11202009359WA patent/SG11202009359WA/en unknown
- 2019-03-22 CN CN201980034629.9A patent/CN113164622A/en active Pending
- 2019-03-22 JP JP2021500505A patent/JP2021535737A/en active Pending
- 2019-03-22 WO PCT/US2019/023694 patent/WO2019183552A2/en unknown
- 2019-03-22 AU AU2019239084A patent/AU2019239084A1/en active Pending
- 2019-03-22 EP EP19772171.5A patent/EP3768329A4/en active Pending
-
2020
- 2020-09-23 IL IL277533A patent/IL277533A/en unknown
-
2024
- 2024-01-11 JP JP2024002727A patent/JP2024029228A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3768329A2 (en) | 2021-01-27 |
KR20210070233A (en) | 2021-06-14 |
CA3094974A1 (en) | 2019-09-26 |
JP2021535737A (en) | 2021-12-23 |
WO2019183552A3 (en) | 2019-10-31 |
US20220120736A1 (en) | 2022-04-21 |
EP3768329A4 (en) | 2022-01-05 |
IL277533A (en) | 2020-11-30 |
WO2019183552A2 (en) | 2019-09-26 |
TW202003051A (en) | 2020-01-16 |
CN113164622A (en) | 2021-07-23 |
AU2019239084A1 (en) | 2020-11-05 |
JP2024029228A (en) | 2024-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277533A (en) | Methods and assays for modulating gene transcription by modulating condensates | |
EP3841577A4 (en) | Pre-distortion for multi-level signaling | |
EP3180785A4 (en) | Systems and methods for speech transcription | |
EP3303636A4 (en) | Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies | |
EP3103046A4 (en) | Biomarker signature method, and apparatus and kits therefor | |
EP3114793A4 (en) | Methods and apparatus for migrating keys | |
EP3210209A4 (en) | Apparatuses and methods for segmented sgs lines | |
EP3196813A4 (en) | Leave of absence prediction system, prediction rule learning device, prediction device, leave of absence prediction method, and computer-readable recording medium | |
EP3648487A4 (en) | Method for updating firmware and related apparatus | |
EP3697911A4 (en) | Method for regulating gene expression | |
EP3167072A4 (en) | Methods and kits for cell-free transcription and translation | |
EP3137902A4 (en) | Novel methods, bioassays, and biomarkers for hpv-related conditions | |
EP3890603A4 (en) | Stress disorder training | |
EP3215150A4 (en) | Inhibitors of myocardin-related transcription factor and serum response factor (mrtf/srf)-mediated gene transcription and methods for use of the same | |
EP3100257A4 (en) | System and method for learning,composing,and playing music with physical objects | |
EP3191629A4 (en) | Peptide microarrays and novel biomarkers for celiac disease | |
EP3799604A4 (en) | Compounds and methods for reducing fxi expression | |
EP3674394A4 (en) | Primary culture method | |
EP3786305A4 (en) | Biomarker for depression and use thereof | |
EP3924952A4 (en) | Improved music fingering aid | |
EP3138908A4 (en) | Novel glycosyltransferase gene and use thereof | |
EP3090497A4 (en) | System and method for pilot tone modulation by data bias | |
EP3892041A4 (en) | Methods, nodes and computer readable media for phr | |
IL280478A (en) | Transcription activator | |
GB201814807D0 (en) | Dementia Biomarkers |